Overview
Ryuhei Masuno practices practicing medicine in Shinjuku, Japan.
Their clinical expertise encompasses Solitary Fibrous Tumor, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ryuhei Masuno
Is Ryuhei Masuno a top-rated expert for Solitary Fibrous Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Ryuhei Masuno is classified as an Experienced expert for Solitary Fibrous Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ryuhei Masuno participate in research or clinical trials?
Yes. Ryuhei Masuno has published 10 articles and abstracts on conditions like Solitary Fibrous Tumor. You can view a list of Ryuhei Masuno's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung AdenocarcinomaMasuno isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerMasuno isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Solitary Fibrous TumorMasuno isExperienced. Learn about Solitary Fibrous Tumor.